Search
Close this search box.

Clinical Trial: ECOG-ACRIN EAQ221CD

ECOG-ACRIN EAQ221CD

Status: Open

Improving Medication Adherence in Metastatic Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP)